00
00898.TW Cathay Genomics Immunology Revolution ETF
- TWD
No recent price
- Total assets
- 1.27B
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- +51.53%
- Holdings
- 10
- Since
- 2021
Fund data as reported by the issuer, updated Nov 8, 2026. Total assets are in the fund's base currency.
What does 00898.TW invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (90.8%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (83.4%)
- Top 3 holdings: 17.5% of the fund
Asset allocation
- US stocks 90.8%
- Non-US stocks 13.3%
- Cash 4.4%
Top holdings
- Iovance Biotherapeutics Inc 7.41%
- Twist Bioscience Corp 5.08%
- Genscript Biotech Corp 5.06%
- 10X Genomics Inc 4.61%
- Natera Inc 4.36%
Cathay Genomics Immunology Revolution ETF performance
Sharpe ratio 0.87- This year
- +40.55%
- 1 year
- +51.53%
- 3 years
- +18.50%
- 5 years
- -
Volatility 21.6% over 1 year and 21.7% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
00898.TW price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Cathay Genomics Immunology Revolution ETF top holdings
41.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Iovance Biotherapeutics Inc IOVA.US | Healthcare | United States | 7.41% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 5.08% |
| Genscript Biotech Corp 1548.HK | Healthcare | Hong Kong | 5.06% |
| 10X Genomics Inc TXG.US | Healthcare | United States | 4.61% |
| Natera Inc NTRA.US | Healthcare | United States | 4.36% |
| Moderna Inc MRNA.US | Healthcare | United States | 3.75% |
| GeneDx Holdings Corp. WGS.US | Healthcare | United States | 3.46% |
| Guardant Health Inc GH.US | Healthcare | United States | 2.83% |
| Caris Life Sciences, Inc. Common Stock CAI.US | Healthcare | United States | 2.71% |
| AbbVie Inc ABBV.US | Healthcare | United States | 2.46% |
00898.TW sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
00898.TW regional exposure
- North America83.4%
- Europe Developed4.8%
- Asia Emerging4.4%
- Asia Developed1.9%
- Australasia1.2%
- Africa/Middle East1.0%
Share of the stocks in the fund.
Company size
Average market cap 613B- Mega cap3.9%
- Big cap17.2%
- Medium cap27.3%
- Small cap38.2%
- Micro cap9.6%
Cathay Genomics Immunology Revolution ETF fund profile
- Fund name
- Cathay Genomics Immunology Revolution ETF
- Ticker
- 00898.TW
- Exchange
- Taiwan Stock Exchange
- Issuer
- -
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Inception date
- Nov 11, 2021
- Trading currency
- TWD
- Expense ratio
- -